MedPage Today on MSN
CAR-T Drug for Myeloma Hit With New Boxed Warning
Ciltacabtagene autoleucel (cilta-cel; Carvykti) for multiple myeloma has a new boxed warning for immune effector ...
The FDA adds a new boxed warning for immune effector cell-associated enterocolitis with Carvykti, but says the overall ...
Preclinical data support Abalos’ first-in-class approach of safely harnessing the immunostimulatory and anti-tumoral properties of arenaviruses to treat solid tumors -- Düsseldorf, Germany, October 14 ...
Researchers at the Medical University of Vienna have taken a closer look at a previously largely unknown component of the ...
News-Medical.Net on MSN
Researchers uncover TRAT1's central role in T helper cell function
Researchers at the Medical University of Vienna have taken a closer look at a previously largely unknown component of the ...
Artificial intelligence (XGBoost) in predicting outcomes among CAR-T therapy patients: The impact of malnutrition and comorbidities using the National Inpatient Sample (2020-2022). Engineering ...
Individuals with post-COVID syndrome had higher immune cell counts after receiving exercise-based rehabilitation vs. usual ...
T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback